27 May 2022 , 01:21 PM
Styptovit-E, a gynecology product having an estimated market size of Rs500 crore (AIOCD data set), will further strengthen Torrent’s presence in the therapy.
The acquisition of these four brands namely, Finast, Finast-T, and Dynapress, which are used in the treatment of Benign Prostatic Hyperplasia (BPH), will further expand Torrent's presence in the Urology therapy.
According to the terms of a definitive agreement, Torrent Pharma will take over the manufacturing, distribution, and marketing of these brands in India. The complete integration and transition of the brands are expected to be finished by June 2022.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.